ArticleToxics2025
Utilizing Molecular Descriptor Importance to Enhance Endpoint Predictions.
Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Quantitative structure-activity relationship (QSAR) models are essential for predicting endpoints that are otherwise challenging to estimate using other in silico approaches. Developing interpretable models for endpoint prediction is valuable as interpretable models may provide valuable insights into the relationship between molecular structure and observed biological or toxicological properties of compounds. In this study, we introduce a novel modification of counter-propagation artificial neural networks that aims to identify key molecular features responsible for classifying molecules into specific endpoint classes. The novel approach presented in this work dynamically adjusts molecular descriptor importance during model training, allowing different molecular descriptor importance values for structurally different molecules, which increases its adaptability to diverse sets of compounds. We applied the method to enzyme inhibition and hepatotoxicity classification datasets. Our findings show that the proposed approach improves the classification of molecules, reduces the number of neurons excited by molecules from different endpoint classes, and increases the number of acceptable models. The proposed approach may be useful in compound toxicity prediction and drug design studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.